Sesquiterpene farnesol as a competitive inhibitor of lipase activity of Staphylococcus aureus

FEMS Microbiology Letters

Volumn 273, Issue 1, 2007, Pages 28-34

  Kuroda, Makoto ^a,b   Nagasaki, Sanae ^a   Ito, Ryuta ^a   Ohta, Toshiko ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Farnesol; Inhibitor; Lipase; Staphylococcus aureus

Indexed keywords

ENZYME INHIBITOR; FARNESOL; METICILLIN; SESQUITERPENE; TRIACYLGLYCEROL LIPASE;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM CULTURE; COMPETITIVE INHIBITION; CONTROLLED STUDY; ENZYME ASSAY; ENZYME INHIBITION; ENZYME PURIFICATION; ENZYME RELEASE; ENZYME SUBSTRATE; HYDROPHOBICITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

CHROMATOGRAPHY, LIQUID; ENZYME INHIBITORS; FARNESOL; LIPASE; PALMITATES; POLYSORBATES; STAPHYLOCOCCUS AUREUS;

STAPHYLOCOCCUS AUREUS;

EID: 34347396156     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2007.00772.x     Document Type: Article

References (26)

1. Akiyama H, Oono T, Huh WK, Yamasaki O, Ogawa S, Katsuyama M, Ichikawa H Iwatsuki K (2002) Actions of farnesol and xylitol against Staphylococcus aureus. Chemotherapy 48 : 122 128.
2. Brehm-Stecher BF Johnson EA (2003) Sensitization of Staphylococcus aureus and Escherichia coli to antibiotics by the sesquiterpenoids nerolidol, farnesol, bisabolol, and apritone. Antimicrob Agents Chemother 47 : 3357 3360.
3. Cowan MM (1999) Plant products as antimicrobial agents. Clin Microbiol Rev 12 : 564 582.
4. Doppalapudi RS, Riccio ES, Rausch LL, Shimon JA, Lee PS, Mortelmans KE, Kapetanovic IM, Crowell JA Mirsalis JC (2007) Evaluation of chemopreventive agents for genotoxic activity. Mutat Res 629 : 148 160.
5. Frosch PJ, Pirker C, Rastogi SC et al 2005) Patch testing with a new fragrance mix detects additional patients sensitive to perfumes and missed by the current fragrance mix. Contact Dermatitis 52 : 207 215.
6. Gotz F, Verheij HM Rosenstein R (1998) Staphylococcal lipases: molecular characterisation, secretion, and processing. Chem Phys Lipids 93 : 15 25.
7. Gupta N, Rathi P Gupta R (2002) Simplified para-nitrophenyl palmitate assay for lipases and esterases. Anal Biochem 311 : 98 99.
8. Inoue Y, Shiraishi A, Hada T, Hirose K, Hamashima H Shimada J (2004) The antibacterial effects of terpene alcohols on Staphylococcus aureus and their mode of action. FEMS Microbiol Lett 237 : 325 331.
9. Jabra-Rizk MA, Meiller TF, James CE Shirtliff ME (2006) Effect of farnesol on Staphylococcus aureus biofilm formation and antimicrobial susceptibility. Antimicrob Agents Chemother 50 : 1463 1469.
10. Katsuyama M, Ichikawa H, Ogawa S Ikezawa Z (2005a) A novel method to control the balance of skin microflora. Part 1. Attack on biofilm of Staphylococcus aureus without antibiotics. J Dermatol Sci 38 : 197 205.
11. Katsuyama M, Kobayashi Y, Ichikawa H, Mizuno A, Miyachi Y, Matsunaga K Kawashima M (2005b) A novel method to control the balance of skin microflora Part 2. A study to assess the effect of a cream containing farnesol and xylitol on atopic dry skin. J Dermatol Sci 38 : 207 213.
12. Kuroda M, Kuroda H, Oshima T, Takeuchi F, Mori H Hiramatsu K (2003) Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus. Mol Microbiol 49 : 807 821.
13. Kuroda M, Nagasaki S Ohta T (2007) Sesquiterpene farnesol inhibits recycling of the C55 lipid carrier of the murein monomer precursor contributing to increased susceptibility to β-lactams in methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 59 : 425 432.
14. Loza-Tavera H (1999) Monoterpenes in essential oils. Biosynthesis and properties. Adv Exp Med Biol 464 : 49 62.
15. Ogawa T, Katsuoka K, Kawano K Nishiyama S (1994) Comparative study of staphylococcal flora on the skin surface of atopic dermatitis patients and healthy subjects. J Dermatol 21 : 453 460.
16. O'Hara M, Kiefer D, Farrell K Kemper K (1998) A review of 12 commonly used medicinal herbs. Arch Fam Med 7 : 523 536.
17. Rollof J, Hedstrom SA Nilsson-Ehle P (1987a) Positional specificity and substrate preference of purified Staphylococcus aureus lipase. Biochim Biophys Acta 921 : 370 377.
18. Rollof J, Hedstrom SA Nilsson-Ehle P (1987b) Purification and characterization of a lipase from Staphylococcus aureus. Biochim Biophys Acta 921 : 364 369.
19. Rosenstein R Gotz F (2000) Staphylococcal lipases: biochemical and molecular characterization. Biochimie 82 : 1005 1014.
20. Sayari A, Agrebi N, Jaoua S Gargouri Y (2001) Biochemical and molecular characterization of Staphylococcus simulans lipase. Biochimie 83 : 863 871.
21. Schnuch A, Uter W, Geier J, Lessmann H Frosch PJ (2004) Contact allergy to farnesol in 2021 consecutively patch tested patients. Results of the IVDK. Contact Dermatitis 50 : 117 121.
22. Shah PM (2005) The need for new therapeutic agents: what is the pipeline? Clin Microbiol Infect 11 : 36 42.
23. Sierra G (1957) A simple method for the detection of lipolytic activity of micro-organisms and some observations on the influence of the contact between cells and fatty substrates. Antonie Van Leeuwenhoek 23 : 15 22.
24. Simons JW, Adams H, Cox RC, Dekker N, Gotz F, Slotboom AJ Verheij HM (1996) The lipase from Staphylococcus aureus. Expression in Escherichia coli, large-scale purification and comparison of substrate specificity to Staphylococcus hyicus lipase. Eur J Biochem 242 : 760 769.
25. Simons JW, van Kampen MD, Riel S, Gotz F, Egmond MR Verheij HM (1998) Cloning, purification and characterisation of the lipase from Staphylococcus epidermidis-comparison of the substrate selectivity with those of other microbial lipases. Eur J Biochem 253 : 675 683.
26. Zetola N, Francis JS, Nuermberger EL Bishai WR (2005) Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 5 : 275 286.